Report Detail

Pharma & Healthcare Global Phenylketonuria (PKU) Market Growth 2019-2024

  • RnM3035587
  • |
  • 27 February, 2019
  • |
  • Global
  • |
  • 138 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Phenylketonuria (PKU) refers to a genetic disorder and the disease is inherited from one’s parents. The patient suffers from a metabolic defect, in which the body stops being able to break down phenylalanine amino acid that is compromised of protein. Phenylalanine starts getting stored in the blood stream and it damages the brain in consequence.
PKU is caused due a defect in the gene which helps to produce phenylalanine hydroxylase. Absence of phenylalanine hydroxylase leads to a buildup of phenylalanine in the body. Timely diagnosis and treatment helps in terminating the symptoms of PKU and avoid brain damage.
The classification of Phenylketonuria (PKU) includes medications, supplements and others, and the revenue proportion of supplements in 2016 is about 34.48% and the revenue proportion of medications is about 42.47%.
Phenylketonuria (PKU) is widely used in household, hospital and other field. The most proportion of Phenylketonuria (PKU) is in household, and the sales proportion in 2016 is about 61.54%.
North America is the largest consumption place, with a consumption market share nearly 57.18% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 29.28%.

According to this study, over the next five years the Phenylketonuria (PKU) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Phenylketonuria (PKU) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Phenylketonuria (PKU) market by product type, application, key manufacturers and key regions and countries.

This study considers the Phenylketonuria (PKU) value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Medications
Supplements
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Household
Hospital

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Biomarin
Vitaflo
Mead Johnson
Nutricia
Abbott
Prominmetabolics
Cambrooke
Juvela
Firstplay Dietary

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Phenylketonuria (PKU) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Phenylketonuria (PKU) market by identifying its various subsegments.
Focuses on the key global Phenylketonuria (PKU) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Phenylketonuria (PKU) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Phenylketonuria (PKU) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Phenylketonuria (PKU) Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Phenylketonuria (PKU) Consumption 2014-2024
        • 2.1.2 Phenylketonuria (PKU) Consumption CAGR by Region
      • 2.2 Phenylketonuria (PKU) Segment by Type
        • 2.2.1 Medications
        • 2.2.2 Supplements
      • 2.3 Phenylketonuria (PKU) Consumption by Type
        • 2.3.1 Global Phenylketonuria (PKU) Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Phenylketonuria (PKU) Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Phenylketonuria (PKU) Sale Price by Type (2014-2019)
      • 2.4 Phenylketonuria (PKU) Segment by Application
        • 2.4.1 Household
        • 2.4.2 Hospital
      • 2.5 Phenylketonuria (PKU) Consumption by Application
        • 2.5.1 Global Phenylketonuria (PKU) Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Phenylketonuria (PKU) Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Phenylketonuria (PKU) Sale Price by Application (2014-2019)

      3 Global Phenylketonuria (PKU) by Players

      • 3.1 Global Phenylketonuria (PKU) Sales Market Share by Players
        • 3.1.1 Global Phenylketonuria (PKU) Sales by Players (2017-2019)
        • 3.1.2 Global Phenylketonuria (PKU) Sales Market Share by Players (2017-2019)
      • 3.2 Global Phenylketonuria (PKU) Revenue Market Share by Players
        • 3.2.1 Global Phenylketonuria (PKU) Revenue by Players (2017-2019)
        • 3.2.2 Global Phenylketonuria (PKU) Revenue Market Share by Players (2017-2019)
      • 3.3 Global Phenylketonuria (PKU) Sale Price by Players
      • 3.4 Global Phenylketonuria (PKU) Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Phenylketonuria (PKU) Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Phenylketonuria (PKU) Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Phenylketonuria (PKU) by Regions

      • 4.1 Phenylketonuria (PKU) by Regions
        • 4.1.1 Global Phenylketonuria (PKU) Consumption by Regions
        • 4.1.2 Global Phenylketonuria (PKU) Value by Regions
      • 4.2 Americas Phenylketonuria (PKU) Consumption Growth
      • 4.3 APAC Phenylketonuria (PKU) Consumption Growth
      • 4.4 Europe Phenylketonuria (PKU) Consumption Growth
      • 4.5 Middle East & Africa Phenylketonuria (PKU) Consumption Growth

      5 Americas

      • 5.1 Americas Phenylketonuria (PKU) Consumption by Countries
        • 5.1.1 Americas Phenylketonuria (PKU) Consumption by Countries (2014-2019)
        • 5.1.2 Americas Phenylketonuria (PKU) Value by Countries (2014-2019)
      • 5.2 Americas Phenylketonuria (PKU) Consumption by Type
      • 5.3 Americas Phenylketonuria (PKU) Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Phenylketonuria (PKU) Consumption by Countries
        • 6.1.1 APAC Phenylketonuria (PKU) Consumption by Countries (2014-2019)
        • 6.1.2 APAC Phenylketonuria (PKU) Value by Countries (2014-2019)
      • 6.2 APAC Phenylketonuria (PKU) Consumption by Type
      • 6.3 APAC Phenylketonuria (PKU) Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Phenylketonuria (PKU) by Countries
        • 7.1.1 Europe Phenylketonuria (PKU) Consumption by Countries (2014-2019)
        • 7.1.2 Europe Phenylketonuria (PKU) Value by Countries (2014-2019)
      • 7.2 Europe Phenylketonuria (PKU) Consumption by Type
      • 7.3 Europe Phenylketonuria (PKU) Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Phenylketonuria (PKU) by Countries
        • 8.1.1 Middle East & Africa Phenylketonuria (PKU) Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Phenylketonuria (PKU) Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Phenylketonuria (PKU) Consumption by Type
      • 8.3 Middle East & Africa Phenylketonuria (PKU) Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Phenylketonuria (PKU) Distributors
      • 10.3 Phenylketonuria (PKU) Customer

      11 Global Phenylketonuria (PKU) Market Forecast

      • 11.1 Global Phenylketonuria (PKU) Consumption Forecast (2019-2024)
      • 11.2 Global Phenylketonuria (PKU) Forecast by Regions
        • 11.2.1 Global Phenylketonuria (PKU) Forecast by Regions (2019-2024)
        • 11.2.2 Global Phenylketonuria (PKU) Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Phenylketonuria (PKU) Forecast by Type
      • 11.8 Global Phenylketonuria (PKU) Forecast by Application

      12 Key Players Analysis

      • 12.1 Biomarin
        • 12.1.1 Company Details
        • 12.1.2 Phenylketonuria (PKU) Product Offered
        • 12.1.3 Biomarin Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Biomarin News
      • 12.2 Vitaflo
        • 12.2.1 Company Details
        • 12.2.2 Phenylketonuria (PKU) Product Offered
        • 12.2.3 Vitaflo Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Vitaflo News
      • 12.3 Mead Johnson
        • 12.3.1 Company Details
        • 12.3.2 Phenylketonuria (PKU) Product Offered
        • 12.3.3 Mead Johnson Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Mead Johnson News
      • 12.4 Nutricia
        • 12.4.1 Company Details
        • 12.4.2 Phenylketonuria (PKU) Product Offered
        • 12.4.3 Nutricia Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Nutricia News
      • 12.5 Abbott
        • 12.5.1 Company Details
        • 12.5.2 Phenylketonuria (PKU) Product Offered
        • 12.5.3 Abbott Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Abbott News
      • 12.6 Prominmetabolics
        • 12.6.1 Company Details
        • 12.6.2 Phenylketonuria (PKU) Product Offered
        • 12.6.3 Prominmetabolics Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Prominmetabolics News
      • 12.7 Cambrooke
        • 12.7.1 Company Details
        • 12.7.2 Phenylketonuria (PKU) Product Offered
        • 12.7.3 Cambrooke Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Cambrooke News
      • 12.8 Juvela
        • 12.8.1 Company Details
        • 12.8.2 Phenylketonuria (PKU) Product Offered
        • 12.8.3 Juvela Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Juvela News
      • 12.9 Firstplay Dietary
        • 12.9.1 Company Details
        • 12.9.2 Phenylketonuria (PKU) Product Offered
        • 12.9.3 Firstplay Dietary Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Firstplay Dietary News

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Phenylketonuria (PKU) . Industry analysis & Market Report on Phenylketonuria (PKU) is a syndicated market report, published as Global Phenylketonuria (PKU) Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Phenylketonuria (PKU) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,917.02
      4,375.53
      5,834.04
      3,400.14
      5,100.21
      6,800.28
      560,821.80
      841,232.70
      1,121,643.60
      305,390.40
      458,085.60
      610,780.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report